The Authorized Generic Playbook: Why Brands Launch Their Own Competition, Even if There is No Competition
Brands Don’t Launch “Competition” by Accident—They Do It to Control the Next Phase of the Market
There’s a quiet strategy playing out across pharma that most investors only notice after the damage is done: the authorized generic.
On the surface, it loo…
